[ad_1]
Thailand begins production of the COVID-19 vaccine Already in the country! Ministry of Public Health Revealing the annual production capacity of 200 million doses, the first batch will be delivered gradually in May 2021. Including ordering the vaccine from a Chinese company Ready to negotiate additional acquisitions for Thais to receive free vaccines from of the state as a goal of not less than 50 percent
Click to follow the live news line from the official account here.
January 3, 2021 In the News Operations Center for Coronavirus 2019, Ministry of Public Health Nonthaburi Province Dr. Supakit Sirilak, Director General of the Department of Medical Sciences With Dr. Nakorn Premsri, Director of the National Vaccine Institute and Dr. Songpol Dee Chongkit CEO Siam Biso Co., Ltd. Press release on the progress of the acquisition of the COVID 19 vaccine
read The doctor opens the film in the lungs, COVID patients continue to spread without symptoms: severe pneumonia.
read Ministry of Public Health requested cooperation Refrain from eating with friends at work to reduce the risk of ‘COVID’
read Quick! Bangkok reminds people to visit cafes in Tha Phra area After the young man caught the coronavirus Singer stuck.
Dr. Supakit said that Government of Thailand by the Ministry of Public Health Have cooperated with many parties. Assure citizens that they will receive their vaccinations at the latest in most countries. Since the middle of last year, the COVID-19 Vaccine Acquisition Committee for Thais has been prepared to research, set goals, work methods and have mechanisms to achieve the vaccine. Since the results of the research are unknown, which vaccines will be successful. Set a free vaccination goal for Thais of at least 50% of the population or approximately 70 million doses by entering into a 26 million dose advance subscription agreement with AstraZeneca. Which uses Oxford University technology.
“Currently in the process of transferring the production process to the Siam Bioscience Company. Deliveries are expected to begin in late May. Another 30 percent are in negotiations with the COVAX facility, concluding an agreement with a vaccine company that is expected to be available. Including negotiations with other companies such as Pfizer, Moderna, Chinese companies Or you can order more from AstraZeneca Also, there is good news that 2 million doses of the vaccine will be obtained from Sinovac, China, approximately 200,000 doses by the end of February, 800,000 to end of March and 1 million at the end of April.
Dr. Supakit went on to say There are few vaccines at this time. Even countries that have started injecting and have started injecting cannot inject all at once. It is not a product that will be readily available on the market. It is important to have a quality and safety control system. Vaccines will not be purchased from substandard factories. Phase 3 trial results are not endorsed by private companies to be sold and must be registered with the FDA, and more importantly, each batch released must be certified by the Department of Medical Sciences. Is consumer protection What Thailand has a mechanism to consider
The committee has gone through a process that confirms that the standards are adequate. Ensuring Thais are vaccinated quickly and safely, even when they have received the vaccine. It will operate in accordance with the principles of vaccine administration. There is a target audience. Vaccination methods Service preparation Quality control From start to finish
Dr. Nakhon said that Currently, there are four types of COVID-19 vaccines approved for emergency use (USA) around the world. Four vaccines, such as mRNA, Viral Vector, Inactivated Protein and Subunit in Thailand, will accept registration in There was a phase 3 effect and the effectiveness was obvious. Only three registered and recognized vaccines are Pfizer, Moderna and AstraZeneca. The rest (AstraZeneca) is an emergency registry that uses only the results of the phase 2 trial, including vaccines from China and Russia. Which previously registered from July-August 2020 The official results of phase 3 have not yet been published AND all currently available COVID-19 vaccines are not yet finalized. Both Pfizer and Modena continued to collect data to look at the effectiveness of the vaccine after three months. Whereas AstraZeneca Thai subscriptions have been approved for emergency vaccine use by the British Regulatory Authority on December 30, 2020.
“More than 5 million doses of the vaccine in 10 countries around the world are due to advance vaccine stocks from July to August 2020. When reserving Preliminary results of the efficacy and safety studies of vaccines There is a very high risk that the vaccine will not be successful and will not be vaccinated For thailand Advance reservations for Phase III vaccines, at risk of not receiving them You have relied on energy emission under the National Vaccine Safety Act BE2561 on October 12, 2020 and has booked a vaccine in November 2020 “
Dr. Nakhon said that Regarding the question of viability that within Jan. By 2021 there will be more vaccinations. But will it reach 100 million doses or not? This depends on the number of vaccines available. Since there are currently a limited number of vaccines. Each company is expanding its production capacity to suit the entire population of the world. This is a great opportunity to learn more about vaccine safety. When vaccines are used in large populations This will make it more likely that you will experience a rare adverse reaction after vaccination. Furthermore, Thailand is not solely focused on AstraZeneca vaccines. The Ministry of Public Health has established a vaccination policy to cover no less than 50% of the Thai population in 2021, which has been implemented in various ways. There are currently discussions with several other vaccine manufacturers. It was not specified that it would collaborate only with a particular manufacturer. No private sector is blocked from importing vaccines into the country. Following a process that must be approved by the FDA to ensure that the vaccine is effective, safe, and meets international standards. In addition, there is a plan to support the registry of vaccines for use in an emergency, the FDA has already prepared and established guidelines for the emergency registry. You can request this information from the Food and Drug Administration
While Dr. Songpol stated that Siam Bioscience Company Knowledge and technology received from AstraZeneca Company Since October 7, 2020, we have prepared the installation, plant, material, equipment, equipment, machinery, currently in the production test phase in order to obtain good quality vaccines. There is a standard equivalent to the central standard. Which is the same standard as AstraZeneca’s global manufacturing plants.There is a production capacity of approximately 200 million doses per year or 15-20 million doses per month will be tested in 5 production cycles, each production cycle with 14 days apart and takes 120 days (4 months) to produce 60 days and 60 days for quality analysis
When producing the first round on December 16, the last Production of the second round, when the production is completed 5 rounds, the results will be sent to the Food and Drug Administration for approval. However, the most important thing in vaccine production is quality and reliability. Make people trust efficient and safe This is as planned and progress will be reported regularly.
read I’ve been starving for many days! A young foreign worker buys at the owl market. Sit down to beat the police station and send them back to the country (clip)
[ad_2]
